What Does Viatris’ Trio Of Attacks On US Semaglutide Mean For Wegovy Generics?

Viatris’ Spate Of Inter Partes Reviews Largely Denied, With One Upside For Firm

 
• By Dean Rudge
  
Novo Nordisk
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Generics Bulletin